SCHEMBL3816059

SCHEMBL3816059

CN1c2ccccc2CCN1C(=O)c1cc2ccc(Br)cn2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.43
GRM5 P41594 5/20 0.42
RAB9A P51151 2/20 0.40
LMNA P02545 2/20 0.40
HSD17B3 P37058 2/20 0.39
BCL2 P10415 1/20 0.39
BAD Q92934 1/20 0.39
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
KMT2A Q03164 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
ALDH1A1 P00352 2/20 0.37
GAA P10253 1/20 0.37
TSHR P16473 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ESR1 P03372 1/20 0.37
POLB P06746 1/20 0.37
ESR2 Q92731 1/20 0.37
CTDSP1 Q9GZU7 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3813937 0.90 GRM5 (0.39) SMN1; SMN2GRM5LMNAHSD17B3ALDH1A1
SCHEMBL3816668 0.90 GRM5 (0.39) GRM5ALDH1A1GAATSHRESR1
SCHEMBL3812491 0.88 NOTUM (0.39) GRM5LMNAALDH1A1GAATSHR
SCHEMBL3820015 0.88 ALDH1A1 (0.40) SMN1; SMN2GRM5RAB9ALMNAALDH1A1
SCHEMBL3813190 0.87 SMN1; SMN2 (0.39) SMN1; SMN2RAB9ALMNAHSD17B3BCL2
SCHEMBL3813124 0.87 GRM5 (0.41) GRM5ALDH1A1GAATSHRESR1
SCHEMBL13720384 0.87 NOTUM (0.40) GRM5HSD17B3ALDH1A1GAAESR1
SCHEMBL3821061 0.87 NOTUM (0.40) GRM5RXFP1ALDH1A1GAATSHR
SCHEMBL3816039 0.87 GRM5 (0.48) GRM5ALDH1A1GAATSHRESR1
SCHEMBL3822131 0.87 GRM5 (0.40) SMN1; SMN2GRM5ALDH1A1GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2090576-A1 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators Merz Pharma GmbH & Co.KGaA (DE) 2009-08-19 EP claimed
EP-2090576-A1 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators Merz Pharma GmbH & Co.KGaA (DE) 2009-08-19 EP disclosed
EP-2090576-A1 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators Merz Pharma GmbH & Co.KGaA (DE) 2009-08-19 EP disclosed
WO-2009095253-A1 6-HALO-PYRAZOLO[1, 5-A]PYRIDINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR (MGLUR) MODULATORS MERZ PHARMA GMBH & CO. KGAA (DE) 2009-08-06 WO disclosed
WO-2009095253-A1 6-HALO-PYRAZOLO[1, 5-A]PYRIDINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR (MGLUR) MODULATORS MERZ PHARMA GMBH & CO. KGAA (DE) 2009-08-06 WO disclosed